Residency · Burlington, VT
Sponsored by University of Vermont Medical Center
Economics of Artificial Intelligence in Healthcare: Diagnosis vs. Treatment.
Healthcare (Basel, Switzerland) · 2022 · 197 citations · David Sobel
Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results.
The Journal of urology · 2023 · 45 citations · Mark Plante
Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH.
The Canadian journal of urology · 2022 · 66 citations · Mark Plante
Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer.
The Journal of urology · 2022 · 65 citations · Jordan Richards
Medical Treatment of Benign Prostatic Hyperplasia.
The Urologic clinics of North America · 2022 · 33 citations · Alexander Plochocki, Benjamin King
COVLIAS 2.0-cXAI: Cloud-Based Explainable Deep Learning System for COVID-19 Lesion Localization in Computed Tomography Scans.
Diagnostics (Basel, Switzerland) · 2022 · 30 citations ·
Presence of an Artificial Intelligence-powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non-muscle-invasive Bladder Cancer.
European urology oncology · 2025 · 12 citations · Jordan Richards
Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results.
BJUI compass · 2022 · 30 citations · Mark Plante